Clinical Trials for Cutaneous Epitheliotropic Lymphoma
Cutaneous epitheliotropic lymphoma, also known as mycosis fungoides, is a rare but aggressive T-cell lymphoma that primarily affects the skin in dogs and occasionally cats. It typically presents as scaling, erythema, or ulceration and can be challenging to diagnose. University research programs are actively studying new immunotherapy and chemotherapy protocols through funded clinical trials to improve outcomes.
7 active trials currently enrolling
Trials available at institutions in:
Understanding Cutaneous Epitheliotropic Lymphoma in Pets
Cutaneous epitheliotropic lymphoma is a rare T-cell lymphoma that primarily affects the skin, most often appearing as patchy, scaling, or thickened areas. It is seen more frequently in dogs than cats.
Who it tends to affect
- Typical size: Affects both dogs and cats
- Typical age: Most commonly diagnosed in older dogs; the age pattern in cats is less well characterized
Can my pet join — does breed matter?
Trials typically enroll based on skin biopsy confirmation and disease extent. Dogs and cats of all breeds are generally eligible.
Most trials are open to all breeds and set requirements by size, weight, age, and diagnosis instead. Our matching service checks your pet's specific details against each study's actual requirements.
Where Cutaneous Epitheliotropic Lymphoma Trials Are Running
Active research locations are spread across the country. Current coverage by region:
States with active sites include: MO, WI, KS, CA. We expand the search to nearby states when there's no local match.
What Cutaneous Epitheliotropic Lymphoma Trials Typically Cost
Many trials cover part or all of treatment costs. Of the 7 trials we're currently tracking for cutaneous epitheliotropic lymphoma:
The trials themselves are run by research institutions — we don't charge for them. Funding status changes as studies open and close, so we confirm current coverage when we match your pet.
What Cutaneous Epitheliotropic Lymphoma Research Is Focused On
Current studies for cutaneous epitheliotropic lymphoma are exploring approaches like:
- •Immunotherapy and immune-modulating drugs
- •New chemotherapy protocols
- •Radiation for localized disease
- •Targeted therapy
How it works
Tell us about your pet
Share the diagnosis, your pet's age and size, and your location. It takes a few minutes — no account needed.
We research current trials
We check open studies against your pet's actual eligibility — diagnosis, stage, location, and prior treatment. Most matches come back in 2–3 days.
You get your matches
A personalized list of trials your pet may qualify for, with locations, funding status, and exactly how to enroll.
The trials themselves are free and run by research institutions. Our fee covers the research and eligibility matching — and if we don't find any matches for your pet, you don't pay.
Find trials for my pet with Cutaneous Epitheliotropic Lymphoma now
Our matching service screens all 7 active Cutaneous Epitheliotropic Lymphoma trials against your pet’s specific profile — age, breed, stage, and location.
$7 to see your matches · $23 only if trials are found
Check My Pet’s Eligibility Now →Find Trials for Your Pet
Our free matching service screens 147 active trials at 25 accredited veterinary universities. Submit once, get matched to every relevant trial.
Find Trials for Your Pet